All practice questions

4736 questions

Question 2321Question →

A 65-year-old patient with a suspected spinal epidural abscess experiences a critical surgical delay because a 'stat' MRI report is electronically routed to an unmonitored inbox over a holiday weekend. The hospital's risk management committee initiates a retrospective investigation to prevent future occurrences.

Arrange the following stages of the ensuing Root Cause Analysis (RCA) in the correct chronological sequence from first to last.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Assemble a multidisciplinary team, construct a chronological timeline, utilize a cause-and-effect diagram, formulate a corrective action plan, and establish continuous monitoring metrics.
A Root Cause Analysis is a structured, retrospective process. It must always begin by defining the problem and forming a multidisciplinary team. The team then gathers data to map out exactly what happened (the timeline). Only after the facts are established can the team analyze why the event happened using tools like the Ishikawa diagram. Finally, the team proposes a corrective action plan and implements outcome measures to monitor long-term success.

Step-by-Step Solution

1
Identify the required quality improvement methodology.
The scenario describes a retrospective investigation of a sentinel event, which mandates a Root Cause Analysis (RCA).
RCA is the standard framework used to investigate adverse events after they have occurred.
2
Determine the initial phase of the RCA framework.
The first step is to assemble a multidisciplinary team.
An effective RCA requires input from individuals with direct knowledge of the processes and systems involved.
3
Establish the sequence of the analytical phases.
Timeline construction must strictly precede cause identification.
Without a factual timeline of what happened, attempts to determine why it happened will be flawed by assumptions and cognitive bias.
4
Determine the concluding phases of the framework.
An action plan is formulated based on the root causes, followed by monitoring metrics.
Interventions must target the explicitly identified root causes, and subsequent monitoring is required to ensure those interventions are successfully sustained.

Key Concept

Root Cause Analysis (RCA) Framework Stages
Question 2322Question →

A 74-year-old woman is admitted to the hospital for the management of newly diagnosed nonvalvular atrial fibrillation. Her past medical history is significant for hypertension and advanced chronic kidney disease. The admitting physician decides to initiate anticoagulation and enters an order for dabigatran at the standard dose of 150 mg twice daily. The patient's most recent comprehensive metabolic panel, drawn earlier that day at an affiliated outpatient clinic, shows a creatinine clearance of 22 mL/min. However, because this lab result was manually scanned into the "Media" tab of the electronic health record rather than populating as discrete data, the computerized provider order entry (CPOE) system's automated renal dosing alert fails to trigger. Thirty minutes later, the clinical pharmacist verifying the orders manually reviews the scanned documents, identifies the severe renal impairment, and contacts the physician. The physician immediately cancels the dabigatran order and prescribes renally adjusted apixaban instead. The patient receives the apixaban and experiences no complications. Which of the following patient safety classifications best describes this sequence of events?

Show answer & explanation

Answer: Near miss

Answer

The correct classification is a near miss.
The correct classification is a near miss (also known as a close call). A near miss is defined as an unsafe act (active error) or a latent system vulnerability that had the potential to cause patient harm but failed to do so because it was intercepted by a robust defense mechanism (in this case, the pharmacist's manual review) or by chance. The physician ordered a medication that was contraindicated for the patient's level of renal function, and the CPOE system failed to alert the physician due to a latent flaw in how outside labs were recorded. However, because the error was caught before the drug was dispensed and administered, the patient suffered no harm, precisely fitting the definition of a near miss.

Step-by-Step Solution

1
Analyze the physician's action and the system's role.
An active error occurred (prescribing a contraindicated dose) compounded by a latent system error (scanned labs not triggering the CPOE alert).
Identifying the types of errors involved is the first step in classifying the overall event.
2
Determine if the error reached the patient.
The clinical pharmacist intercepted the error before the medication was dispensed or administered.
The distinction between an adverse event and a near miss depends entirely on whether the error reached the patient.
3
Assess for patient harm.
No harm occurred because the patient received the correct, modified medication.
Adverse events and sentinel events require actual patient harm, whereas a near miss involves an intercepted error with no harm.

Key Concept

Classification of Patient Safety Events
Question 2323Question →

An infection prevention committee at a regional transplant center is updating the screening protocol for asymptomatic carriage of carbapenem-resistant Enterobacteriaceae (CRE). The current protocol utilizes a single rapid molecular assay on perirectal swabs. While this assay is highly sensitive, its moderate specificity has led to numerous false-positive results. Consequently, many patients are unnecessarily placed in strict contact isolation, which depletes hospital resources and delays transfers.

To address this issue, the committee approves a new two-step diagnostic algorithm. Under the new protocol, patients will first undergo the rapid molecular assay. If the initial assay is positive, a second, independent phenotypic culture test will be performed. A patient will be considered a confirmed CRE carrier and placed in isolation only if both the rapid assay and the phenotypic culture yield positive results.

Compared to the previous single-test protocol, which of the following best describes the expected statistical impact of implementing this new testing algorithm on the screening pathway's overall performance characteristics?

Show answer & explanation

Answer: Decreased sensitivity, increased specificity, and increased positive predictive value

Answer

The new algorithm will result in decreased sensitivity, increased specificity, and increased positive predictive value.
The scenario describes a sequential (or series) testing strategy. In sequential testing, a patient is only considered to have the disease if both Test A and Test B are positive. This strict requirement eliminates many false positives, thereby increasing the overall specificity of the screening pathway. Because there are fewer false positives in the isolated group, the positive predictive value (PPV) also increases. However, the trade-off is an increase in false negatives (e.g., a patient with CRE who tests positive on the molecular assay but falsely negative on the culture), which consequently decreases overall sensitivity.

Step-by-Step Solution

1
Identify the type of diagnostic strategy being implemented.
The scenario describes sequential (series) testing, where a second confirmatory test is only performed if the first test is positive.
Recognizing the strategic architecture is required to determine how composite statistical metrics will shift.
2
Determine the impact of sequential testing on overall sensitivity and specificity.
Overall specificity increases because false positives from the first test are filtered out by the second test. Overall sensitivity decreases because some true positives from the first test will incorrectly test negative on the second test.
Sequential testing maximizes the ability to rule in a disease by sacrificing some ability to rule it out.
3
Deduce the downstream impact on predictive values.
Because specificity increases (yielding fewer false positives), the positive predictive value (PPV) increases. Because sensitivity decreases (yielding more false negatives), the negative predictive value (NPV) decreases.
Predictive values are mathematically tied to sensitivity, specificity, and the underlying prevalence in the tested population.

Key Concept

Sequential Testing Strategies and Performance Characteristics
Question 2324Question →

An international cardiovascular research consortium examines the efficacy of a novel synthetic GLP-1 receptor agonist in preventing major adverse cardiovascular events (MACE). The study follows adults with type 2 diabetes and established atherosclerotic disease over a 4-year period. Event frequencies are documented as follows:

- GLP-1 receptor agonist group: 80 events out of 1,000 patients
- Placebo group: 120 events out of 1,000 patients

The researchers report a two-sided pp-value of 0.0040.004 for the overall difference in MACE incidence. During a secondary analysis, the investigators stratify the data by baseline statin use. In the subgroup of patients taking statins, the relative risk (RR) for MACE with the GLP-1 receptor agonist is 0.430.43 (95% CI:0.28−0.6595\% \text{ CI}: 0.28 - 0.65). In the subgroup of patients not taking statins, the RR is 1.01.0 (95% CI:0.85−1.1895\% \text{ CI}: 0.85 - 1.18).

Based on the overall cohort data, what is the number needed to treat (NNT) to prevent one MACE, and which epidemiological concept best explains the findings of the statin-stratified analysis?

Show answer & explanation

Answer: NNT = 25; Effect modification

Answer

NNT = 25; Effect modification
The correct answer combines accurate NNT calculation with the proper interpretation of stratified data. First, the Absolute Risk Reduction (ARR) is the difference in event rates between the placebo and treatment groups: 0.12−0.08=0.040.12 - 0.08 = 0.04. The Number Needed to Treat (NNT) is the inverse of the ARR: 10.04=25\frac{1}{0.04} = 25. This means 25 patients must be treated for 4 years to prevent one MACE. Second, the study evaluates the role of statins. The crude (overall) Relative Risk (RR) is 0.080.12=0.67\frac{0.08}{0.12} = 0.67. When stratified by statin use, the RRs are profoundly different from each other (0.430.43 vs. 1.01.0). Because the effect of the GLP-1 agonist varies based on the presence of a statin, statin use is acting as an effect modifier, not a confounder.

Step-by-Step Solution

1
Calculate the incidence of MACE in both groups.
Control Incidence (IcI_c) = 120/1000=0.12120 / 1000 = 0.12. Intervention Incidence (IeI_e) = 80/1000=0.0880 / 1000 = 0.08.
Baseline risks are required to determine the absolute risk reduction.
2
Calculate the Absolute Risk Reduction (ARR).
ARR = Ic−Ie=0.12−0.08=0.04I_c - I_e = 0.12 - 0.08 = 0.04 (or 4%4\%).
ARR represents the actual difference in risk attributable to the intervention.
3
Calculate the Number Needed to Treat (NNT).
NNT = 1ARR=10.04=25\frac{1}{\text{ARR}} = \frac{1}{0.04} = 25.
NNT is the reciprocal of the absolute risk reduction.
4
Interpret the stratified analysis to distinguish between confounding and effect modification.
The RR for statin users (0.430.43) is significantly different from the RR for non-users (1.01.0). This indicates effect modification.
When a third variable fundamentally changes the magnitude or direction of the association between an exposure and an outcome, it is an effect modifier. If it were a confounder, the stratified RRs would be similar to each other.

Key Concept

Calculating NNT using Absolute Risk Reduction and distinguishing effect modification (differing stratified relative risks) from confounding.
Question 2325Question →

A 35-year-old pediatric intensivist arrives at the hospital to begin a day shift in the pediatric intensive care unit. The intensivist receives sign-out from a 42-year-old colleague who has just completed a 12-hour night shift. During the transition of care, the arriving intensivist notices that the colleague has noticeably slurred speech, ataxia, and a strong odor of alcohol on their breath. The colleague states that they need to insert a central venous catheter in a newly admitted patient before heading home. Which of the following is the most appropriate next step for the arriving intensivist?

Show answer & explanation

Answer: Intervene to stop the colleague from performing the procedure and notify the departmental chief.

Answer

Intervene to stop the colleague from performing the procedure and notify the departmental chief.
The correct answer correctly identifies the dual responsibility of a physician when encountering an impaired colleague: immediate intervention to ensure patient safety and subsequent reporting to institutional leadership. Because the colleague intends to perform a central venous catheter insertion while exhibiting clear signs of alcohol intoxication, the observing physician must step in immediately to prevent the procedure. Once the patient is safe, the incident must be reported to the departmental chief, chief medical officer, or the hospital's physician health program to ensure proper evaluation and prevent future patient harm.

Step-by-Step Solution

1
Identify the immediate threat to patient safety.
The colleague exhibits clear signs of alcohol intoxication (slurred speech, ataxia, alcohol odor) and intends to perform an invasive procedure.
Recognizing impairment is the first step in fulfilling the ethical duty to protect patients.
2
Determine the required intervention to mitigate the immediate risk.
The impaired physician must be immediately prevented from having any patient contact or performing any procedures.
Patient safety is the absolute highest priority in situations of physician impairment.
3
Identify the appropriate reporting mechanism.
The incident must be reported to the appropriate clinical authority, such as the departmental chief, chief medical officer, or physician health program.
Mandatory reporting ensures the physician is safely removed from duty, evaluated, and offered rehabilitation, protecting both current and future patients.

Key Concept

When a physician is suspected of being impaired, the paramount responsibility is to immediately intervene to protect patient safety, followed by reporting the individual to the appropriate institutional authority.
Question 2326Question →

A 75-year-old man is evaluated in the emergency department for severe stomatitis, fever, and generalized weakness. One week ago, he visited his primary care clinic for osteoarthritis, and his physician intended to prescribe the nonsteroidal anti-inflammatory drug meloxicam. However, due to a drop-down menu proximity error in the electronic health record (EHR), the physician accidentally selected methotrexate with instructions for daily use. The patient's pharmacy dispensed the medication as ordered. The patient took the methotrexate daily, leading to acute severe pancytopenia and mucosal toxicity. He is admitted to the hospital for treatment with intravenous leucovorin and broad-spectrum antibiotics. The primary care clinic's medical director is notified of the adverse event. Which of the following is the most appropriate next step for the clinic's leadership?

Show answer & explanation

Answer: Assemble a multidisciplinary team to conduct a root cause analysis of the clinic's electronic prescribing system and workflows

Answer

Assemble a multidisciplinary team to conduct a root cause analysis of the clinic's electronic prescribing system and workflows.
The correct action is to initiate a root cause analysis (RCA). RCA is a retrospective, multidisciplinary process used to identify the underlying systemic and structural factors (latent errors) that contributed to an adverse event. In this scenario, the RCA would examine EHR design, drop-down menu proximity, and the lack of automated alerts for daily methotrexate dosing, aligning with the principles of a 'just culture.'

Step-by-Step Solution

1
Identify the nature of the patient safety incident.
A severe adverse event has occurred due to a prescribing error (wrong medication selected in EHR), resulting in patient harm.
Determining the severity and type of event guides the required institutional response.
2
Determine the appropriate investigative framework for a retrospective event.
A root cause analysis (RCA) is required.
RCA is the standard retrospective tool used to identify systemic vulnerabilities and latent errors after an adverse event has reached the patient.
3
Evaluate the distractors against patient safety principles.
Punitive actions, premature closure, prospective analyses (FMEA), and delayed investigations are incorrect.
Modern patient safety relies on a 'just culture' that addresses system flaws immediately and thoroughly rather than assigning individual blame.

Key Concept

Root cause analysis (RCA) is a retrospective, systems-based approach used to investigate adverse events and identify underlying system vulnerabilities rather than focusing on individual blame.
Question 2327Question →

Physicians face numerous legal and ethical boundaries regarding financial relationships, industry interactions, and patient referrals. Match each professional scenario described below with the corresponding legal statute or ethical violation it most directly represents.

Click a left item, then click its matching right item

Items

A cardiologist refers Medicare patients to a freestanding magnetic resonance imaging (MRI) facility in which she holds a 20% equity stake, with no safe harbor exceptions met.
An orthopedic surgeon accepts cash remuneration from a medical device manufacturer that scales directly with the volume of joint replacement prostheses he implants in federally insured patients.
A neurologist serving on a hospital pharmacy and therapeutics committee votes to add a novel migraine medication to the formulary while actively hiding a lucrative consulting contract with the drug's maker.
A primary care clinician accepts an all-expenses-paid trip, including luxury lodging, directly from a pharmaceutical company to attend an accredited continuing medical education (CME) symposium.

Matches

Show answer & explanation

Answer

The scenarios correctly pair as follows: The MRI facility referral matches the Stark Law violation; the volume-based device payments match the Anti-Kickback Statute violation; the undisclosed formulary vote matches an unmanaged institutional conflict of interest; and the sponsored CME trip matches the violation of AMA ethical guidelines regarding industry gifts.
Each scenario illustrates a distinct, fundamental violation of medical ethics or federal law governing healthcare finance. The Stark Law applies strictly to self-referrals for designated health services. The Anti-Kickback Statute applies to remuneration provided to generate federal healthcare business. Institutional conflicts of interest occur when personal financial gain compromises administrative decision-making. Finally, AMA guidelines strictly forbid direct industry funding for physician CME attendance.

Step-by-Step Solution

1
Analyze the first scenario involving the cardiologist's referral for MRI.
The physician has an equity stake in the MRI facility and refers Medicare patients there. MRI is a designated health service.
Identifying self-referral for designated health services without a safe harbor points directly to the Stark Law.
2
Evaluate the second scenario involving the orthopedic surgeon.
The surgeon receives cash tied directly to the volume of joint replacements.
Volume-based remuneration intended to induce or reward the use of specific devices in federal healthcare patients is a hallmark of an Anti-Kickback Statute violation.
3
Examine the third scenario regarding the neurologist on the formulary committee.
The physician advocates for a drug made by a company she secretly consults for.
Failure to disclose this financial relationship while in an administrative decision-making position constitutes an unmanaged institutional conflict of interest.
4
Assess the final scenario concerning the primary care clinician's CME travel.
The physician accepts direct travel and lodging expenses from a pharmaceutical company.
The AMA Code of Medical Ethics explicitly dictates that any industry support for CME must be given to the conference sponsor, and physicians cannot accept direct travel or lodging subsidies from industry.

Key Concept

Conflicts of Interest in Medical Practice and Federal Healthcare Laws
Question 2328Question →

Match each clinical scenario describing a patient safety incident to the most accurate event classification and its corresponding administrative or clinical next step.

Click a left item, then click its matching right item

Items

A pharmacist intercepts a physician's order for a tenfold overdose of methotrexate before the medication is dispensed or administered.
An electronic health record interface requires physicians to scroll down to view patient allergies, a flaw that has contributed to multiple prescribing mistakes.
A patient dies from a hemolytic transfusion reaction after receiving ABO-incompatible blood due to a processing mix-up in the laboratory.
A patient develops a mild, reversible rash after a resident physician inadvertently prescribes a medication to which the patient has a documented allergy.

Matches

Show answer & explanation

Answer

The intercepted methotrexate order is a near miss; the EHR flaw is a latent condition; the fatal transfusion is a sentinel event; and the allergic reaction is a preventable adverse event requiring open disclosure.
Proper classification of medical errors dictates the appropriate administrative and clinical response. A near miss highlights system resilience but requires reporting to address the vulnerability. Latent conditions are systemic flaws that predispose to mistakes and require redesign. Sentinel events are severe outcomes requiring formal root cause analysis. Preventable adverse events require immediate open disclosure to the patient, clinical management, and internal reporting.

Step-by-Step Solution

1
Analyze each scenario to determine if the error reached the patient and the severity of the outcome.
The methotrexate order did not reach the patient; the EHR is an underlying flaw; the transfusion caused death; the allergy prescription caused a mild rash.
Determining patient impact is essential for distinguishing between near misses, adverse events, and sentinel events.
2
Match the intercepted error to its classification and next step.
Intercepted methotrexate order matches 'Near Miss', requiring an internal incident report.
Errors caught before patient exposure are near misses, which provide valuable data for system improvement without causing harm.
3
Match the systemic flaw to its classification and next step.
The EHR scrolling issue matches 'Latent Condition', requiring workflow redesign.
Latent conditions are built-in system vulnerabilities that set up front-line workers for active errors.
4
Match the fatal outcome to its classification and next step.
The fatal transfusion matches 'Sentinel Event', requiring a formal Root Cause Analysis and regulatory notification.
Sentinel events involve unexpected death or severe injury and mandate rigorous, standardized investigation.
5
Match the error causing mild harm to its classification and next step.
The allergic reaction matches 'Preventable Adverse Event', requiring patient disclosure and clinical care.
When an error reaches the patient and causes harm, ethical principles mandate open disclosure alongside incident reporting.

Key Concept

Classification of Patient Safety Events and Administrative Pathways
Question 2329Question →

A 71-year-old man is evaluated in the hospital for a transition to comfort-focused care. He has a history of ischemic cardiomyopathy for which a left ventricular assist device (LVAD) was implanted as destination therapy three years ago. Two months ago, he was diagnosed with widely metastatic pancreatic adenocarcinoma and has experienced rapid functional decline. He is now completely bedbound, cachectic, and experiencing poorly controlled abdominal pain despite escalating doses of intravenous opioids. During a family meeting, the patient, who demonstrates clear decision-making capacity, requests to be discharged to home hospice. He also explicitly requests that his LVAD be deactivated once he arrives home, stating, "I am ready to die naturally, and I do not want this machine keeping my body alive anymore." The cardiology team expresses concern that turning off the implanted device is ethically and legally equivalent to physician-assisted suicide. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Arrange for home hospice discharge and coordinate with the palliative team to deactivate the LVAD at the patient's residence.

Answer

Arrange for home hospice discharge and coordinate with the palliative team to deactivate the LVAD at the patient's residence.
The correct response is to honor the patient's request to be discharged home and coordinate the deactivation of the LVAD with the hospice team. Ethically and legally, an LVAD is a life-sustaining medical treatment. There is no distinction between withholding or withdrawing an LVAD and other forms of life support, such as mechanical ventilation, hemodialysis, or artificial nutrition. A patient with decision-making capacity has the absolute right to refuse or request withdrawal of any medical intervention, even if doing so will predictably result in death. Turning off the device allows the patient's underlying severe cardiomyopathy to follow its natural course; it does not constitute active euthanasia or physician-assisted suicide. Furthermore, LVAD deactivation can be safely managed in the home hospice setting provided that preemptive symptom management (e.g., administering opioids and benzodiazepines for anticipated dyspnea and anxiety) is arranged.

Step-by-Step Solution

1
Assess the patient's medical condition and prognosis.
The patient has a terminal malignancy with weeks to live and is suffering from refractory symptoms.
Establishes the clinical context for transitioning to comfort measures only.
2
Evaluate the patient's capacity and request.
The patient has clear decision-making capacity and requests LVAD deactivation upon returning home.
A patient with capacity has the absolute legal and ethical right to refuse any medical treatment, including life-sustaining therapy.
3
Apply ethical principles to the specific device.
LVADs are considered life-sustaining medical treatments, legally and ethically equivalent to mechanical ventilators or hemodialysis.
Withdrawing an LVAD allows the underlying disease to take its natural course; it is distinct from physician-assisted suicide or active euthanasia.
4
Determine the appropriate care setting.
Discharge to home hospice with coordinated deactivation is planned.
LVAD deactivation can safely and ethically be performed at home with appropriate hospice support and anticipatory symptom management protocols.

Key Concept

Ethical and Legal Permissibility of Withdrawing Left Ventricular Assist Devices (LVADs)
Question 2330Question →

A 61-year-old man comes to the clinic for a routine follow-up examination. He has a history of hypertension, hyperlipidemia, a transient ischemic attack 3 months ago, and a seizure disorder resulting from a head injury 10 years ago. His seizures have been well controlled on levetiracetam. His other medications include aspirin, atorvastatin, and lisinopril. The patient smokes 1 pack of cigarettes daily. He reports no respiratory symptoms. During the interview, he states, "I know I need to quit smoking, especially after that mini-stroke. I tried going cold turkey last month but only lasted two days before the cravings drove me crazy. I read online about pills that can block the cravings, but my neighbor said they cause severe psychiatric problems. I was thinking of just taking St. John's wort to calm my nerves when I try again. Honestly, if quitting is going to make me lose my mind or if the cravings are always this bad, I might as well just keep smoking." Which of the following is the most appropriate initial response by the physician?

Show answer & explanation

Answer: It sounds like you are feeling discouraged, but the fact that you managed to stop for two days shows you possess the commitment needed to succeed.

Answer

The most appropriate response uses reflective listening and affirmation to address the patient's discouragement and build self-efficacy.
The correct response utilizes core techniques of Motivational Interviewing (MI), specifically reflective listening and affirmation. The patient is expressing a desire to quit but is hindered by low self-efficacy stemming from a recent failed attempt and fear of medication side effects. By reflecting his emotional state ('feeling discouraged') and reframing his two-day abstinence as a success rather than a failure, the physician builds the patient's confidence. This crucial psychological foundation must be established before navigating the complex, shared decision-making required to safely select a pharmacologic cessation aid for a patient with multiple comorbidities.

Step-by-Step Solution

1
Analyze the patient's stage of change and current psychological barriers.
The patient is in the contemplation/preparation stage but exhibits significant ambivalence and very low self-efficacy due to a recent failed quit attempt.
Identifying the psychological barrier dictates the communication strategy. Education or prescribing will fail if the patient lacks confidence in their ability to succeed.
2
Evaluate the clinical appropriateness of the pharmacologic interventions mentioned in the stem.
Bupropion is contraindicated due to the patient's seizure disorder. St. John's wort is contraindicated due to a CYP3A4 interaction with his prescribed atorvastatin.
Before offering medical advice or agreeing to patient-proposed treatments, a physician must screen for absolute contraindications and drug-drug interactions.
3
Select the best initial communication strategy based on Motivational Interviewing (MI) principles.
The best initial step is to use the OARS (Open questions, Affirmation, Reflective listening, Summarizing) framework. Affirming his past effort (quitting for two days) directly targets his low self-efficacy.
In outpatient behavioral counseling, establishing rapport, validating concerns, and building the patient's confidence must precede the collaborative selection of a safe cessation aid (such as nicotine replacement therapy or varenicline).

Key Concept

In patients demonstrating low self-efficacy and ambivalence toward behavioral change, the initial application of Motivational Interviewing techniques—specifically reflective listening and affirmation of past efforts—is the most appropriate next step to build confidence and therapeutic alliance.
Question 2331Question →

A physician is conducting an annual wellness examination for a patient with stable angina and mild chronic obstructive pulmonary disease. While updating the medical record, the physician notes that the patient still actively uses tobacco. To structure the brief intervention for tobacco cessation, the physician employs the widely recommended '5 A's' behavioral counseling framework. Arrange the following statements made by the physician into the correct chronological sequence according to this established protocol.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence follows the evidence-based 5 A's model for tobacco cessation: Ask (identify use), Advise (urge to quit), Assess (determine willingness), Assist (help with a plan), and Arrange (schedule follow-up).
The 5 A's model for treating tobacco use and dependence outlines a specific chronological sequence. First, the physician must 'Ask' about tobacco use to identify it at every visit. Second, the physician must strongly 'Advise' the patient to quit. Third, the physician must 'Assess' the patient's willingness to make a quit attempt. Fourth, if the patient is ready, the physician should 'Assist' in the quit attempt through counseling and pharmacotherapy. Finally, the physician must 'Arrange' follow-up contact to monitor progress and prevent relapse.

Step-by-Step Solution

1
Identify the clinical counseling framework being tested.
The scenario requires the application of the '5 A's' model for tobacco cessation intervention, endorsed by the USPSTF.
Recognizing the framework provides the necessary structure to sequence the physician's communication.
2
Recall the correct sequence of the 5 A's framework.
The correct standardized order is: Ask, Advise, Assess, Assist, Arrange.
This sequence ensures that all patients are systematically identified, universally advised to quit regardless of current motivation, evaluated for readiness, provided with actionable help if ready, and followed up for maintenance.
3
Map the physician's quoted statements to each specific step and arrange them chronologically.
The sequence aligns as follows: inquiring about daily cigarette count (Ask), delivering the strong clinical message to quit (Advise), inquiring about willingness to try quitting (Assess), formulating the treatment plan with patches (Assist), and planning the follow-up phone call (Arrange).
Matching the clinical dialogue directly to the structural framework confirms the correct chronological order.

Key Concept

The 5 A's model is a validated, evidence-based behavioral counseling framework for tobacco cessation consisting of five sequential steps: Ask, Advise, Assess, Assist, and Arrange.
Question 2332Question →

A 28-year-old man comes to the clinic to review recent laboratory results. He was recently diagnosed with HIV, and his CD4 cell count is 450/mm3450/\text{mm}^3. A screening interferon-gamma release assay is positive, and a chest radiograph is normal, consistent with latent tuberculosis infection (LTBI). The physician recommends initiating antiretroviral therapy (ART) alongside a 3-month course of weekly isoniazid and rifapentine. The patient becomes visibly upset and states, "I am not taking all those toxic drugs. A friend told me that concentrated garlic supplements and a strict vegan diet can clear these infections naturally. I do not want to poison my body with pharmaceuticals." He works as a yoga instructor and has no other medical history. His physical examination is unremarkable.

Which of the following responses by the physician is the most appropriate?

Show answer & explanation

Answer: It sounds like you have strong concerns about the safety of these medications. Can you tell me more about what 'poisoning your body' means to you in this context?

Answer

The most appropriate initial response is to validate the patient's emotional response and use open-ended inquiry to explore his specific health beliefs and barriers to medical adherence.
The correct answer employs open-ended inquiry to explore the patient's perspective. By validating the patient's concerns and asking him to elaborate on what "poisoning your body" means, the physician builds a therapeutic alliance and identifies specific barriers to adherence. This is the foundational step in motivational interviewing (the 'O' in OARS: Open-ended questions), which must occur before the physician can effectively address misconceptions about natural remedies or explain the physiological consequences of untreated infections.

Step-by-Step Solution

1
Identify the primary clinical challenge presented in the vignette.
A patient with newly diagnosed HIV and latent tuberculosis is expressing profound reluctance to start standard pharmacological therapies due to fears of toxicity and a preference for alternative natural remedies.
Recognizing the underlying psychological and emotional drivers of nonadherence is the required first step in formulating an effective counseling strategy.
2
Evaluate the proposed counseling approaches against the principles of patient-centered communication.
The optimal approach initially focuses on building a therapeutic alliance through the exploration of the patient's perspective rather than engaging in immediate confrontation or coercion.
Directly challenging the patient's beliefs without first understanding them typically entrenches resistance and damages the physician-patient relationship.
3
Rule out distractors that disguise factually incorrect medical management as counseling.
Options proposing contraindicated therapies (TNF-alpha inhibitors), misstating pharmacokinetic mechanisms (garlic as a CYP inhibitor instead of an inducer), misapplying guidelines (LDCT for a 28-year-old), or misunderstanding ethical concepts (capacity vs. competence) are eliminated.
Physician counseling must remain grounded in accurate evidence-based medicine, ethical principles, and sound pharmacology.

Key Concept

Patient-centered communication and motivational interviewing require initially exploring a patient's illness narrative and validating their emotions before attempting to correct misconceptions.
Estimated Time:1m 30s
Question 2333Question →

A 67-year-old man presents to the outpatient clinic to establish primary care. His medical history is significant for essential hypertension and compensated cirrhosis secondary to hepatitis C virus (HCV) infection. He completed a course of direct-acting antivirals 4 years ago and achieved a sustained virologic response. He smoked half a pack of cigarettes daily from age 20 to 45 (12.5 pack-years) but quit 22 years ago. His most recent colonoscopy was performed at age 60 and revealed no polyps or abnormalities. He received the two-dose recombinant zoster vaccine series at age 65 but has not received any other vaccinations in adulthood. Which of the following preventive interventions are indicated for this patient today? (Select exactly 3)

Select all that apply

Show answer & explanation

Answer: Hepatic ultrasonography; One-time duplex ultrasonography of the abdominal aorta; 20-valent pneumococcal conjugate vaccine

Answer

The indicated interventions are hepatic ultrasonography, one-time duplex ultrasonography of the abdominal aorta, and the 20-valent pneumococcal conjugate vaccine.
Hepatic ultrasonography is indicated because patients with cirrhosis require hepatocellular carcinoma surveillance every 6 months, regardless of the fact that the underlying Hepatitis C was cured. One-time duplex ultrasonography of the abdominal aorta is indicated because the patient is a male between the ages of 65 and 75 who has smoked at least 100 cigarettes in his lifetime. The 20-valent pneumococcal conjugate vaccine is indicated as standard age-based prophylaxis for all adults aged 65 and older who are pneumococcal vaccine-naïve.

Step-by-Step Solution

1
Evaluate the patient's liver disease history and current screening requirements.
The patient has cirrhosis from prior HCV. Despite HCV cure, the presence of cirrhosis mandates lifelong hepatocellular carcinoma surveillance via ultrasound every 6 months.
HCV cure stops viral damage, but established cirrhosis maintains a high baseline risk of malignant transformation.
2
Analyze the patient's smoking history against vascular and pulmonary screening guidelines.
The patient is a 67-year-old man with a 12.5 pack-year history who quit 22 years ago. He qualifies for AAA screening but not lung cancer screening.
Abdominal aortic aneurysm screening requires only a lifetime history of 100 cigarettes for men aged 65-75. Lung cancer screening requires a 20 pack-year history AND current smoking or quitting within the past 15 years.
3
Review the patient's immunization history and age-based requirements.
The patient is over 65 and has not received a pneumococcal vaccine. PCV20 is indicated.
Adults aged 65 and older should receive PCV20 (or PCV15 followed by PPSV23) if they lack a history of pneumococcal conjugate vaccination.
4
Assess the patient's colorectal cancer screening status.
The patient had a normal colonoscopy at age 60. No additional screening is needed at age 67.
The standard interval following a normal colonoscopy in an average-risk individual is 10 years. Performing a FIT test before age 70 is inappropriate.

Key Concept

Application of preventive screening guidelines requires careful parsing of specific risk thresholds (e.g., smoking pack-years vs. lifetime exposure) and recognizing that some risks (like HCC in cirrhosis) persist even when the underlying etiology is cured.
Question 2334Question →

A 54-year-old man presents to the clinic to establish primary care after recently relocating. He feels well, has no current symptoms, and has not been evaluated by a physician in five years. His medical history is significant for essential hypertension, which is well-controlled on amlodipine. His social history is notable for having smoked 1 pack of cigarettes daily from age 20 until he quit at age 42. He consumes alcohol occasionally. His family history is notable for a father diagnosed with prostate cancer at age 70. Preventive care history reveals that he underwent a screening colonoscopy 9 years ago at age 45, which was completely normal. He received a Tdap booster 5 years ago but has no record of receiving any other adult vaccinations. Physical examination reveals a blood pressure of 126/78 mmHg, heart rate of 72/min, and a BMI of 26 kg/m². The remainder of the examination is unremarkable.

Which of the following preventive interventions are indicated for this patient today? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: 20-valent pneumococcal conjugate vaccine (PCV20); Annual low-dose computed tomography (LDCT) of the chest

Answer

The indicated interventions are the 20-valent pneumococcal conjugate vaccine (PCV20) and annual low-dose computed tomography (LDCT) of the chest.
The correct interventions are LDCT and PCV20. Annual LDCT of the chest is recommended by the USPSTF for adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. This patient is 54, has a 22 pack-year history, and quit 12 years ago, fully meeting the criteria. Furthermore, based on current ACIP guidelines, routine pneumococcal vaccination (e.g., PCV20) is now recommended for all adults aged 50 years and older, regardless of underlying medical conditions. Because this patient is 54 and has no record of prior pneumococcal vaccination, it is indicated today.

Step-by-Step Solution

1
Calculate the patient's smoking pack-years and years since quitting.
The patient smoked 1 pack/day for 22 years (age 20 to 42), totaling 22 pack-years. He is currently 54 and quit at 42, meaning he quit 12 years ago.
Lung cancer screening criteria rely heavily on exact pack-years and the time elapsed since smoking cessation.
2
Evaluate eligibility for lung cancer screening based on current USPSTF guidelines.
LDCT is indicated because the patient falls within the 50-80 age range, has a ≥20 pack-year history, and quit within the last 15 years.
Failing to recognize that the patient is still within the 15-year window since quitting is a common diagnostic oversight.
3
Assess the patient's immunization requirements based on updated ACIP schedules.
PCV20 is indicated because the Advisory Committee on Immunization Practices (ACIP) updated its guidelines to recommend routine pneumococcal vaccination for all adults aged 50 and older.
Keeping up-to-date with recent age-threshold changes for immunizations is critical for effective preventive care.
4
Review the remaining options against specific age and interval guidelines.
Colonoscopy is excluded (due at year 10; currently at year 9). AAA ultrasound is excluded (starts at age 65). ECG is excluded (Grade D recommendation for asymptomatic low-risk adults).
Prevents overutilization of screening modalities and adheres strictly to evidence-based intervals.

Key Concept

Age and risk-based application of preventive screening and immunization guidelines.
Question 2335Question →

A medical advisory board for a high-risk gastroenterology clinic is refining the screening protocol for cholangiocarcinoma using a novel continuous serum assay. Elevated assay levels correlate closely with the presence of disease. Initial guidelines placed the diagnostic threshold at the 95th percentile of asymptomatic controls. However, because delayed detection of this malignancy leads to near-universal mortality, the board modifies the protocol to explicitly minimize the incidence of Type II errors. What is the most likely statistical consequence of modifying this threshold?

Show answer & explanation

Answer: The probability that a patient with a negative test actually has the malignancy will decrease.

Answer

The probability that a patient with a negative test actually has the malignancy will decrease.
The medical advisory board seeks to minimize Type II errors, which correspond directly to false-negative results. To achieve this, the test's sensitivity must be maximized by lowering the diagnostic threshold. When the threshold is lowered, more patients cross the line to test positive. This simultaneously decreases the number of false negatives and increases the number of false positives. Negative Predictive Value (NPV) is defined as the proportion of negative results that are true negatives, calculated as TN / (TN + FN). Because the threshold adjustment deliberately minimizes false negatives (the denominator), the NPV increases. The false omission rate is the mathematical complement of NPV (1 - NPV) and represents the probability that a patient with a negative test actually has the disease. Because NPV increases, this specific probability decreases, ensuring fewer cases of cholangiocarcinoma are missed.

Step-by-Step Solution

1
Identify the clinical meaning of a Type II error in this diagnostic context.
A Type II error represents a false-negative result (failing to detect the malignancy when present).
Understanding the clinical goal requires translating it into standard epidemiological terminology.
2
Determine the parameter shift required to minimize false negatives.
To decrease false-negative results, the test's sensitivity must be maximized by lowering the diagnostic cutoff threshold.
Lowering the cutoff threshold captures more true positive cases, though it inherently sacrifices specificity.
3
Analyze the impact of lowering the cutoff on predictive values.
Lowering the cutoff decreases false negatives and increases false positives. Consequently, the Negative Predictive Value (NPV) increases, while the Positive Predictive Value (PPV) decreases.
NPV is calculated as TN / (TN + FN). As FN approaches zero, NPV approaches 100%.
4
Evaluate the answer choices against these statistical shifts.
The probability that a patient with a negative test has the disease is the False Omission Rate (1 - NPV). Since NPV increases, this probability must decrease.
This confirms the correct option.

Key Concept

Minimizing Type II errors (false negatives) requires lowering the diagnostic threshold, which increases test sensitivity and negative predictive value (NPV) while decreasing specificity and positive predictive value (PPV).
Estimated Time:1m 30s
Question 2336Question →

Match each epidemiological or clinical research scenario with the most appropriate statistical measure of association or impact that should be calculated.

Click a left item, then click its matching right item

Items

A public health department investigates a community outbreak of gastroenteritis to determine the absolute excess incidence of disease directly attributable to consuming water from a contaminated well.
Investigators design a retrospective study selecting infants with a rare congenital cardiac defect and healthy controls to evaluate the association with maternal use of a specific anticonvulsant.
A randomized controlled trial assesses a new monoclonal antibody's efficacy in reducing cardiovascular mortality over 10 years, modeling the instantaneous rate of death while accounting for varying patient follow-up times and dropouts.
A hospital pharmacy committee evaluates a newly approved oral anticoagulant to determine the absolute number of patients that must be treated to result in one additional major gastrointestinal bleed compared to standard therapy.
A national task force aims to estimate the proportion of all lung cancer cases in the general population that could theoretically be prevented if all cigarette smoking were completely eliminated.

Matches

Show answer & explanation

Answer

1 maps to Attributable Risk (AR); 2 maps to Odds Ratio (OR); 3 maps to Hazard Ratio (HR); 4 maps to Number Needed to Harm (NNH); 5 maps to Population Attributable Fraction (PAF).
Each scenario maps to a unique statistical measure. Case-control designs necessitate Odds Ratios. Survival analysis requires Hazard Ratios to account for censoring. Public health questions regarding exposed groups use Attributable Risk, while population-wide prevention estimates rely on the Population Attributable Fraction. Finally, patient-level counseling on adverse events utilizes Number Needed to Harm.

Step-by-Step Solution

1
Analyze the first scenario focusing on the 'absolute excess incidence' in a specific exposed group.
Matches Attributable Risk (AR).
AR is calculated as Incidenceexposed−Incidenceunexposed\text{Incidence}_{\text{exposed}} - \text{Incidence}_{\text{unexposed}} and represents the excess risk linked to the exposure.
2
Analyze the second scenario involving selection based on disease status (rare cardiac defect vs. healthy).
Matches Odds Ratio (OR).
This is a case-control study. Relative Risk (RR) cannot be calculated because incidence is unknown; OR is the required measure of association.
3
Analyze the third scenario involving 'instantaneous rate of death', 'varying follow-up times', and 'dropouts'.
Matches Hazard Ratio (HR).
Survival analysis using Cox proportional hazards modeling yields an HR, which accounts for time-to-event and right-censoring (dropouts).
4
Analyze the fourth scenario asking for the 'absolute number of patients that must be treated' to cause one 'additional major gastrointestinal bleed'.
Matches Number Needed to Harm (NNH).
NNH translates the Absolute Risk Increase (ARI) into a clinically actionable number: NNH=1/ARI\text{NNH} = 1 / \text{ARI}.
5
Analyze the fifth scenario aiming to estimate the 'proportion of all cases in the general population' that could be prevented.
Matches Population Attributable Fraction (PAF).
PAF accounts for both the relative risk of the exposure and the prevalence of the exposure in the general population, making it the standard metric for public health impact.

Key Concept

Selection of the correct measure of association or impact depends heavily on study design (e.g., case-control vs. cohort), the handling of time (e.g., fixed follow-up vs. survival analysis), and the scope of interpretation (e.g., exposed cohort vs. general population).
Estimated Time:2m 0s
Question 2337Question →

A 55-year-old man is evaluated in the urology clinic for an elevated prostate-specific antigen (PSA) level. Based on his age, family history, and prostate volume, his pretest probability for clinically significant prostate cancer is determined to be 20%20\%. To decide whether to perform an invasive transrectal ultrasound-guided prostate biopsy, the physician orders a novel urinary biomarker panel. The physician's clinical protocol dictates that a biopsy will only be deferred if a negative biomarker result reduces the patient's post-test probability of cancer to strictly less than 5%5\%.

The laboratory's traditional cutoff threshold for a 'positive' result on this biomarker panel yielded a sensitivity of 90%90\% and a specificity of 80%80\%. However, to reduce the hospital-wide burden of unnecessary biopsies in the general screening population, the laboratory's quality committee recently raised the cutoff threshold for a positive result. This adjustment increased the assay's specificity to 95%95\% but decreased its sensitivity to 76%76\%.

Based on the new laboratory threshold compared to the traditional one, which of the following best describes the mathematical impact on the interpretation of a negative test result for this patient?

Show answer & explanation

Answer: The negative predictive value decreases, resulting in a post-test probability of disease greater than 5% and necessitating a biopsy

Answer

The negative predictive value decreases, resulting in a post-test probability of disease greater than 5% and necessitating a biopsy.
Moving the cutoff threshold to increase a test's specificity requires stronger evidence (higher biomarker levels) for a positive result, which inevitably decreases the test's sensitivity. A decrease in sensitivity increases the false-negative rate. Mathematically, the negative likelihood ratio (LR−LR-) is calculated as (1−Sensitivity)/Specificity(1 - \text{Sensitivity}) / \text{Specificity}. The traditional LR−LR- was (1−0.90)/0.80=0.125(1 - 0.90) / 0.80 = 0.125. The new LR−LR- is (1−0.76)/0.95≈0.253(1 - 0.76) / 0.95 \approx 0.253. Because the LR−LR- has mathematically increased, a negative test result is now less capable of ruling out the disease. For this patient with a 20%20\% pretest probability (pretest odds of 0.250.25), the post-test odds of disease with a negative result rise from 0.0310.031 to 0.0630.063. Converting back to probabilities, the post-test probability increases from 3.03%3.03\% to 5.94%5.94\%. Because this new probability exceeds the physician's strict 5%5\% safety threshold, the biopsy can no longer be deferred. Consequently, the negative predictive value (NPV) of the test has decreased for this patient, demonstrating the clinical paradox that optimizing a test to reduce false positives can simultaneously force unnecessary invasive procedures on patients who test negative.

Step-by-Step Solution

1
Calculate the patient's pretest odds of having clinically significant prostate cancer.
Pretest odds = 0.20/(1−0.20)=0.20/0.80=0.250.20 / (1 - 0.20) = 0.20 / 0.80 = 0.25.
Bayes' theorem requires pretest odds to calculate post-test odds using likelihood ratios.
2
Calculate the negative likelihood ratio (LR−LR-) for both the traditional and new cutoff thresholds.
Traditional LR−LR- = (1−0.90)/0.80=0.10/0.80=0.125(1 - 0.90) / 0.80 = 0.10 / 0.80 = 0.125. New LR−LR- = (1−0.76)/0.95=0.24/0.95≈0.253(1 - 0.76) / 0.95 = 0.24 / 0.95 \approx 0.253.
LR−LR- quantifies how much the odds of disease decrease when a diagnostic test result is negative.
3
Calculate the post-test odds for a negative result under both threshold conditions.
Traditional post-test odds = 0.25×0.125≈0.0310.25 \times 0.125 \approx 0.031. New post-test odds = 0.25×0.253≈0.0630.25 \times 0.253 \approx 0.063.
Post-test odds are the product of the pretest odds and the likelihood ratio.
4
Convert the post-test odds back to post-test probabilities and compare to the physician's 5%5\% deferral threshold.
Traditional post-test probability = 0.031/(1+0.031)≈3.03%0.031 / (1 + 0.031) \approx 3.03\% (biopsy would be deferred). New post-test probability = 0.063/(1+0.063)≈5.94%0.063 / (1 + 0.063) \approx 5.94\% (biopsy is now required).
The clinical decision is based on an absolute probability threshold, which requires converting odds back into standard probability.

Key Concept

Impact of diagnostic cutoff threshold adjustments on likelihood ratios and post-test probabilities
Question 2338Question →

An internal medicine physician is seeing multiple patients in the outpatient clinic today. Each patient presents a unique communication challenge related to health behavior change, diagnosis acceptance, or counseling. Match each patient statement (Left) with the most appropriate, targeted physician communication strategy or motivational interviewing technique (Right).

Click a left item, then click its matching right item

Items

Patient on chronic opioids: 'I know these pills are dangerous and I hate being dependent on them, but every time I try to cut back, the pain makes it impossible to go to work.'
Patient managing obesity: 'I completely blew it over the holidays and regained 5 pounds. I have absolutely no willpower; I might as well just give up on this whole weight loss effort.'
Patient with newly diagnosed HIV: 'I understand the results say I have HIV, but I feel completely fine. There must have been a mix-up with the blood samples. I'm going to get retested somewhere else.'
Patient discussing smoking cessation: 'Okay, I'm truly ready to quit smoking. I've thrown out all my ashtrays and bought the nicotine patches. What exactly should I do next?'
Parent discussing pediatric care: 'I read online that the MMR vaccine causes neurological issues. I don't want to risk my child's brain development just to prevent a childhood rash.'

Matches

Show answer & explanation

Answer

Opioid ambivalence matches Double-sided reflection; Obesity weight regain matches Cognitive reframing; HIV diagnosis denial matches Rolling with resistance; Smoking cessation readiness matches Collaborative action planning; Vaccine hesitancy matches Elicit-Provide-Elicit framework.
Each targeted counseling strategy is specifically tailored to the psychological phenomenon presented. Double-sided reflection addresses ambivalence. Reframing addresses all-or-nothing thinking after a lapse. Rolling with resistance maintains the alliance when encountering acute denial. Action planning capitalizes on high readiness. The Elicit-Provide-Elicit model gently introduces factual information when confronting entrenched misinformation.

Step-by-Step Solution

1
Analyze each patient statement to identify the specific psychological state, defense mechanism, or stage of change.
Opioid patient: Contemplation/Ambivalence. Obesity patient: Relapse/Abstinence violation effect. HIV patient: Denial. Smoking patient: Preparation/Action. Vaccine parent: Misinformation/Hesitancy.
Identifying the underlying psychological barrier or stage of change is the prerequisite for selecting the correct targeted communication strategy.
2
Select the evidence-based communication or motivational interviewing technique designed for each specific psychological state.
Contemplation requires double-sided reflection. Relapse despair requires cognitive reframing. Denial requires rolling with resistance. Preparation requires action planning. Misinformation requires the Elicit-Provide-Elicit framework.
Applying mismatched strategies (e.g., action planning for a contemplative patient, or confronting a patient in denial) leads to poor clinical outcomes and damages the therapeutic alliance.

Key Concept

Targeted physician communication strategies must directly align with the patient's specific readiness to change, emotional state, or cognitive barrier as defined by the Transtheoretical Model and Motivational Interviewing principles.
Estimated Time:1m 30s
Question 2339Question →

Match each clinical scenario involving an incapacitated patient with the most appropriate legal or ethical standard that dictates the medical decision-making process.

Click a left item, then click its matching right item

Items

A 24-year-old man arrives unresponsive with hemorrhagic shock following a motor vehicle collision and requires an emergent laparotomy. No family is present.
The daughter of a 78-year-old man with advanced dementia declines a feeding tube for him, stating, 'He always told me he never wanted to be kept alive like this if he couldn't recognize his family.'
A state-appointed guardian must make a medical decision for a 40-year-old woman who has had profound global developmental delay since birth and has never possessed decision-making capacity.
An 82-year-old woman with metastatic cancer becomes unresponsive. The medical team withholds intubation based on her legally executed Physician Orders for Life-Sustaining Treatment (POLST) form.

Matches

Show answer & explanation

Answer

1. Emergency doctrine, 2. Substituted judgment, 3. Best interest standard, 4. Prior expressed wishes
Each clinical vignette maps directly to a foundational legal and ethical standard in medical ethics: the emergency doctrine applies to emergent implied consent without a surrogate; substituted judgment applies when a surrogate decides based on the patient's known values; the best interest standard applies when acting to maximize benefit if patient wishes are completely unknown or the patient never possessed capacity; and the execution of expressed wishes applies when following explicit legal documents like an advance directive or POLST.

Step-by-Step Solution

1
Analyze the capacity status and available documentation or surrogate for each patient scenario.
Each scenario involves an incapacitated patient, but the source of the treatment decision varies (none, surrogate, guardian, formal document).
Identifying the decision-maker or guiding document determines the applicable ethical framework.
2
Examine the trauma scenario with no surrogate or documentation.
Matches with Emergency doctrine (Implied consent).
Immediate life-saving interventions without consent are justified by implied consent in true emergencies.
3
Evaluate the dementia patient with a daughter acting as surrogate based on past statements.
Matches with Substituted judgment standard.
The surrogate is substituting her judgment for the patient's based on known values and prior conversations.
4
Assess the lifelong cognitively impaired patient with a guardian.
Matches with Best interest standard.
Because the patient never possessed capacity, no past wishes exist to substitute; decisions must focus purely on clinical benefit and well-being.
5
Review the patient with a completed POLST form.
Matches with Execution of prior expressed wishes.
The patient's own documented decisions from when they had capacity directly govern care.

Key Concept

Ethical Frameworks for Surrogate Decision Making
Question 2340Question →

A state health department conducts a retrospective cohort analysis to evaluate the safety of a new targeted biologic therapy for moderate-to-severe plaque psoriasis. The investigators specifically monitor the incidence of herpes zoster reactivation over a 3-year follow-up period, comparing patients on the new biologic therapy to a separate cohort receiving traditional systemic agents.

The study results are summarized in the following table:

Treatment GroupTotal PatientsHerpes Zoster Cases
Targeted biologic therapy2,500175
Traditional systemic agents4,000120

Assuming these results are statistically significant, what is the number needed to harm (NNH) for the targeted biologic therapy compared to traditional systemic agents?

Show answer & explanation

Answer: 25

Answer

25
The number needed to harm (NNH) represents the number of patients who must be exposed to a risk factor or medication over a specified period to cause one additional adverse event. It is calculated mathematically as the inverse of the Absolute Risk Increase (NNH=1ARINNH = \frac{1}{ARI}). To find the ARI, first determine the incidence of the adverse event in both groups. The incidence in the targeted biologic group is 1752500=0.07\frac{175}{2500} = 0.07 (7%). The incidence in the traditional systemic agents group is 1204000=0.03\frac{120}{4000} = 0.03 (3%). The ARI is the difference between these two rates (0.07−0.03=0.040.07 - 0.03 = 0.04). The NNH is therefore 10.04=25\frac{1}{0.04} = 25. This indicates that for every 25 patients treated with the targeted biologic therapy instead of traditional agents, one additional case of herpes zoster reactivation will occur.

Step-by-Step Solution

1
Calculate the incidence of the adverse event in the exposed group (biologic therapy).
Iexposed=1752500=0.07I_{exposed} = \frac{175}{2500} = 0.07
To determine the absolute risk of herpes zoster in the population receiving the new treatment.
2
Calculate the incidence of the adverse event in the unexposed control group (traditional agents).
Iunexposed=1204000=0.03I_{unexposed} = \frac{120}{4000} = 0.03
To establish the baseline risk of herpes zoster reactivation without the new treatment.
3
Calculate the Absolute Risk Increase (ARI).
ARI=Iexposed−Iunexposed=0.07−0.03=0.04ARI = I_{exposed} - I_{unexposed} = 0.07 - 0.03 = 0.04
ARI represents the excess risk of the adverse event that is specifically attributable to the new biologic therapy.
4
Calculate the Number Needed to Harm (NNH).
NNH=1ARI=10.04=25NNH = \frac{1}{ARI} = \frac{1}{0.04} = 25
NNH translates the absolute risk difference into a clinical metric, showing how many patients must be treated to observe one additional adverse event.

Key Concept

The Number Needed to Harm (NNH) is calculated as the inverse of the Absolute Risk Increase (ARI). It requires calculating the incidence rates for both exposed and unexposed groups, finding their difference, and taking the inverse.
Estimated Time:1m 30s
PreviousPage 117 / 237Next